StockNews.com Begins Coverage on Can-Fite BioPharma (NYSE:CANF)

Stock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of NYSE CANF opened at $2.09 on Tuesday. The company has a market capitalization […]

Related Keywords

Fite Biopharma ,Fite Biopharma Ltd ,Securities Exchange Commission ,Schechter Investment Advisors ,Can Fite Biopharma ,Get Free Report ,Investment Advisors ,Free Report ,Can Fite Biopharma Daily ,Nyse Canf ,Ocanf ,Medical ,Initiated Coverage ,Stocknews Com ,